EICHORCondition: Breast Neoplasms · Radiotherapy · Lymphedema · Sponsor: Ontario Clinical Oncology Group (OCOG)
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The primary objective of this study is to determine if hypofractionated RT delivered over 1 week to the breast or chest wall and regional nodes (26Gy in 5 daily fractions) following BCS or mastectomy, is non-inferior to conventional fractionation to the breast or chest wall and regional nodes delivered over 3 weeks (40Gy in 15 daily fractions) in patients with node-positive breast cancer.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Tom Baker Cancer Centre | Calgary, Alberta, Canada | — |
| Cross Cancer Institute | Edmonton, Alberta, Canada | — |
| BC Cancer - Centre for the Southern Interior | Kelowna, British Columbia, Canada | — |
| BC Cancer - Centre for the North | Prince George, British Columbia, Canada | — |
| BC Cancer - Vancouver Centre | Vancouver, British Columbia, Canada | — |
| BC Cancer - Vancouver Island Centre | Victoria, British Columbia, Canada | — |
| Northeast Cancer Centre, Health Sciences North | Greater Sudbury, Ontario, Canada | — |
| Juravinski Cancer Centre | Hamilton, Ontario, Canada | — |
| London Regional Cancer Program | London, Ontario, Canada | — |
| The Ottawa Hospital Regional Cancer Centre | Ottawa, Ontario, Canada | — |
| Sunnybrook Health Sciences Centre - Odette Cancer Centre | Toronto, Ontario, Canada | — |
| Princess Margaret Cancer Centre - UHN | Toronto, Ontario, Canada | — |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04228991